上海胜普泽泰医药科技有限公司致力于创新型、难成药、前瞻性靶点的多肽创新药研发，利用20年真实数据积累的新药发现平台“Chemical Space”，以人工智能和药物结构大数据为驱动，为全球制药企业提供一站式多肽创新药研发服务。

公司在全球各地设立5个模块中心。总部在上海，AI与新药发现中心在瑞士巴塞尔，化学合成中试基地在福建漳州，临床前研究基地在福建厦门以及位于江苏泰兴的大型多肽API生产基地。

公司通过以虚拟筛选与湿实验结合的方式，按照客户指标交付经细胞、动物实验等验证的创新药专利分子，并为客户开发新药分子的生产工艺以及生产用于临床、商业化的原料药。

Space Peptides is committed to R&D of innovative peptide drugs with innovative, difficult to produce drugs and forward-looking targets，by utilizing "Chemical Space", a new drug discovery platform based on accumulation of 20 years’ real data, is driven by artificial intelligence and big data on drug structure to provide one-stop drug R&D services for global pharmaceutical companies.

The company has set up five module centers around the world. The headquarters is in Shanghai, the AI and New Drug Discovery Center is in Basel, Switzerland, the pilot chemical synthesis base is in Zhangzhou, Fujian, the preclinical research base is in Xiamen, Fujian, and the peptide API production base is in Taixing, Jiangsu. 

By combining virtual screening with wet experiments, Space Peptides deliver innovative drug patent molecules verified by cell and animal experiments according to customer indexes, and develop the production process of new drug molecules for customers as well as the production of API for clinical and commercial use.